Latest Texas News

xReality Group Limited has reported its strongest quarter yet, with record cash receipts and a doubling sales pipeline, underpinned by major US defence contracts and expanded production capacity.

Black Bear Minerals has completed its acquisition of the Shafter Silver Project in Texas, revealing exceptional surface sampling results and commencing maiden drilling. Meanwhile, its Independence Gold Project in Nevada reports outstanding gold recoveries, underpinning a strong growth outlook.

Brookside Energy delivered steady production and strong cash flow from its Anadarko Basin assets in the December 2025 quarter, while advancing its Riverbend project and continuing an active share buy-back program.

New Frontier Minerals has completed its maiden drilling campaign at Harts Range and secured a binding commercial framework with Metallium Ltd, unlocking a novel processing pathway for heavy rare earth elements. Meanwhile, progress at its NWQ Copper Project and a successful capital raise position the company for growth.

Metallium Limited has kicked off commissioning at its Texas Technology Campus, sealed a multi-year feedstock deal with Glencore, and bolstered its balance sheet with a A$75 million capital raise, setting the stage for commercialisation in 2026.

Otto Energy reported stable oil and gas production for the December quarter, supported by a strong cash position and strategic board changes. Despite a dip in oil prices, the company’s focus on cash flow and cost management positions it well for the year ahead.

Top End Energy has strategically expanded into the US AI data center sector, positioning itself as a key land and energy partner to meet surging power demands.

Lithium Universe’s Bécancour Lithium Refinery project in Québec is poised to capitalise on a sharp lithium price rebound, with current prices well above feasibility study forecasts. The company’s counter-cyclical development strategy is gaining momentum amid renewed market confidence.

Singular Health Group has advanced its U.S. commercial footprint with the deployment of 500 new licences under its PNS contract and secured FDA clearance for its cloud-based 3DICOM MD® platform, positioning the company for significant growth.

Island Pharmaceuticals has secured key regulatory milestones for its antiviral Galidesivir, including FDA confirmation of the Animal Rule pathway and Priority Review Voucher eligibility, while strengthening US biodefense ties and expanding patent protection.

Metallium Limited has raised A$75 million in a strategic capital round led by U.S. institutional investors, accelerating its commercial operations in Texas and setting the stage for a NASDAQ listing later this year.

Lynas Rare Earths reported a 43% year-on-year revenue increase to A$201.9 million in Q2 FY26 despite a 30% drop in key NdPr production due to power disruptions and maintenance. The company also announced CEO Amanda Lacaze’s planned retirement at year-end.